Clearmind Medicine Inc (CMND) saw an uptrend of 6.04% in the recent trading with $1.58 being its most recent. The current price level -55.87% lower than the highest price of $3.58 marked by the stock while trading over the past 52-weeks, whereas it is 71.65% higher than the lowest price of $0.92 the company dropped to over past 52-weeks. The latest news story on CMND appeared in (GlobeNewswire) under the title “Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment”.
Squeezing the time span to 30 day period shows us the stock is currently trading -27.52% below one month high and is +38.60% above of the lowest during that time. Looking into the simple moving average, Clearmind Medicine Inc (CMND)’s stock stands at a SMA-50 of $1.3913 while that of 5-day is reading $1.4600.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and CMND’s SMA-200 as of now is $1.3369.
Clearmind Medicine Inc Earnings – What Happened With CMND
Coming around sales and income figures on CMND Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
CMND – Clearmind Medicine Inc Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 3.98 million. CMND does have institutional investors; and they hold 22.16% of the stock.
Clearmind Medicine Inc – Insider Activity and Holdings
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Clearmind Medicine Inc has a debt to equity ratio of 0.02.
Technical Analysis of Clearmind Medicine Inc (NASDAQ:CMND) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Clearmind Medicine Inc (CMND), we notice that the stock’s 20-day average volume is at 2,908,785 shares and 50% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 1,221,466 shares. And to end, CMND’s 100-day average volume is 839,047 shares with 100% of the long-term indicators pointing towards Buy for the stock.
